Progesterone Receptor Agonists and Antagonists as Anticancer Agents

被引：3
|
作者：
Chakraborty, A. [1 ]
Chatterjee, S. [1 ]
Roy, P. [1 ]
机构：
[1] Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee 247667, Uttar Pradesh, India
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2010年 / 10卷 / 06期
关键词：
Progesterone receptor; progestagens; agonists; antagonists; anti-cancer; HORMONE REPLACEMENT THERAPY; BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVITY; PENICILLIUM-OBLATUM; INHIBITORY FUNCTION; ENDOMETRIAL CANCER; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION;
D O I：
10.2174/138955710791384108
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Progesterone is a major female steroid hormone produced by the ovarian corpus luteum and by the placental syncyiotrophoblast during the second trimester. The biological effects of this steroid hormone are mediated by the ubiquitously expressed progesterone receptor. The exact link between progesterone and female reproductive organ cancer is a controversial issue with various cross-talks. The present review summarizes recent trends in the development of some (anti) progestagen in the cure and management of breast and uterine cancers.
引用
收藏
页码：506 / 517
页数：12
相关论文
共 50 条
  • [1] Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists
    Lin, Hsiang-Ru
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (15) : 3626 - 3632
  • [2] Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
    Singhal, Hari
    Greene, Marianne E.
    Zarnke, Allison L.
    Laine, Muriel
    Al Abosy, Rose
    Chang, Ya-Fang
    Dembo, Anna G.
    Schoenfelt, Kelly
    Vadhi, Raga
    Qiu, Xintao
    Rao, Prakash
    Santhamma, Bindu
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Long, Henry W.
    Becker, Lev
    Brown, Myles
    Greene, Geoffrey L.
    ONCOTARGET, 2018, 9 (04) : 4282 - 4300
  • [3] The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents
    Makkouk, Amani
    Abdelnoor, Alexander M.
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2009, 31 (03) : 331 - 338
  • [4] Novel mechanisms of progesterone antagonists and progesterone receptor
    Edwards, DP
    Leonhardt, SA
    Gass-Handel, E
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2000, 7 (01) : S22 - S24
  • [5] Novel Mechanisms of Progesterone Antagonists and Progesterone Receptor
    Dean P. Edwards
    Susan A. Leonhardt
    Elizabeth Gass-Handel
    The Journal of the Society for Gynecologic Investigation: JSGI, 2000, 7 : S22 - S24
  • [6] CONFORMATION OF ACETYLCHOLINE-RECEPTOR IN THE PRESENCE OF AGONISTS AND ANTAGONISTS
    WU, CSC
    SUN, XH
    YANG, JT
    JOURNAL OF PROTEIN CHEMISTRY, 1990, 9 (01): : 119 - 126
  • [7] Identification of novel agonists and antagonists of the ecdysone receptor by virtual screening
    Hu, Xueping
    Yin, Bin
    Cappelle, Kaat
    Swevers, Luc
    Smagghe, Guy
    Yang, Xinling
    Zhang, Li
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 81 : 77 - 85
  • [8] CENTRALLY ACTIVE 5-HT RECEPTOR AGONISTS AND ANTAGONISTS
    MIDDLEMISS, DN
    TRICKLEBANK, MD
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) : 75 - 82
  • [9] Novel class of non-steroidal progesterone receptor antagonists
    Zhi, L
    Marschke, KB
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (06) : 695 - 700
  • [10] Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton
    Nishiyama, Yuko
    Mori, Shuichi
    Makishima, Makoto
    Fujii, Shinya
    Kagechika, Hiroyuki
    Hashimoto, Yuichi
    Ishikawa, Minoru
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07): : 641 - 645
12345